Magnetic resonance (MR) imaging is a relatively new method of examinin
g the liver. Attempts have been made to optimize the method by develop
ing new imaging techniques and introducing new contrast agents. The ne
w imaging techniques have improved the image quality by shortening the
examination time, reducing motion artifacts, and improving contrast-t
o-noise ratio. Contrast agents have improved the diagnosis of focal he
patic lesions in MR imaging in several ways. Extracellular gadolinium
chelates have significantly improved the characterization of lesions,
and can be optimally used as a problem-solving method for differentiat
ing focal lesions of an unknown nature that have already been detected
by other imaging modalities or by unenhanced MR imaging. Hepatobiliar
y and macrophage monocytic phagocytic system (MMPS)-targeted contrast
agents have improved the detection of hepatic lesions. These agents ar
e best used for preoperative evaluation of the exact number of lesions
in patients with primary or secondary hepatic neoplasms.